Lisinopril
Who holds supplier records for Lisinopril? 11 organisations hold a current record for Lisinopril: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (2), Germany (1) and Spain (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lisinopril: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lisinopril
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Lisinopril expires 6 Nov 2035. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lisinopril. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 16510, 38132 · latest filing Mar 2023
- EVONIK OPERATIONS GMBHGermanyCEP Company GMP cert on recordActive DMF 19138 · latest filing Jan 2006
- Lupin LimitedIndiaCEP Company GMP cert on recordActive DMF 15098 · latest filing Oct 2000
- Zhejiang Changming Pharmaceutical Co.,LtdChinaCEPActive DMF 27385 · latest filing Sept 2013
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 14801 · latest filing Mar 2000
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 35620 · latest filing Mar 2021
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 44603 · latest filing Aug 2026
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 41701 · latest filing Mar 2025
- UNIMARK REMEDIES LTDIndiaActive DMF 17626 · latest filing Aug 2004
- FARMHISPANIA SASpainCEPInactive DMF 11535 · latest filing May 1995
- RICHTER THEMIS MEDICARE I PVT LTDCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Lisinopril, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2011-002 - Rev 01 Lisinopril dihydrate | Aug 2025 | — |
| RICHTER THEMIS MEDICARE (I) PVT. LTD. Vapi | IN | CEP 2018-223 - Rev 01 Lisinopril dihydrate | May 2025 | Inspected Jan 2026 Hungary |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2022-237 - Rev 02 Lisinopril dihydrate, Anhydride Process | Jul 2024 | Inspected May 2026 Italy |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2022-434 - Rev 02 Lisinopril dihydrate, Process-III | Jul 2024 | — |
| EVONIK OPERATIONS GMBH Essen | DE | R1-CEP 2004-011 - Rev 07 Lisinopril dihydrate | Dec 2020 | — |
| LUPIN LIMITED Mumbai | IN | R1-CEP 2001-311 - Rev 04 Lisinopril dihydrate | Sept 2019 | — |
| Farmhispania, S.A. Montmeló | ES | R1-CEP 2005-249 - Rev 02 Lisinopril dihydrate | Apr 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Lisinopril are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- MYLAN LABORATORIES LTDInactive DMF 21206 · filed Dec 2007
- India · Inactive DMF 18117 · filed Feb 2005
- India · Inactive DMF 18104 · filed Feb 2005
- India · Inactive DMF 14995 · filed Aug 2000
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 14774 · filed Mar 2000
- ESTEVE QUIMICA SAInactive DMF 12968 · filed Apr 1998
- Hungary · Inactive DMF 12912 · filed Jan 1998
- ZENECA PHARMACEUTICALSInactive DMF 7141 · filed Sept 1987
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (80 listed products contain Lisinopril). The latest listed patent expires 6 Nov 2035. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily in the treatment of high blood pressure and heart failure. It helps to relax blood vessels, making it easier for the heart to pump blood.
Chemical identity
- IUPAC name
- (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;dihydrate
- Canonical SMILES
- C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O.O.O
- InChIKey
- CZRQXSDBMCMPNJ-ZUIPZQNBSA-N
- Synonyms
- Lisinopril dihydrate, Prinivil, Zestril, lisinopril hydrate, mk-521, nsc-751176, nsc-758151, prinzide component lisinopril, ranolip, zestoretic component lisinopril
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
- Mechanism of action
- Angiotensin-converting Enzyme Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lisinopril?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Lisinopril: Hetero Drugs Limited (India), EVONIK OPERATIONS GMBH (Germany), Lupin Limited (India), Zhejiang Changming Pharmaceutical Co.,Ltd (China), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Emcure Pharmaceuticals Limited (India), LEE PHARMA LTD (India) and MSN LIFE SCIENCES PRIVATE LIMITED (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lisinopril Drug Master Files are active?
Hetero Drugs Limited (DMF 16510, 38132), EVONIK OPERATIONS GMBH (DMF 19138), Lupin Limited (DMF 15098), Zhejiang Changming Pharmaceutical Co.,Ltd (DMF 27385), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 14801), Emcure Pharmaceuticals Limited (DMF 35620), LEE PHARMA LTD (DMF 44603) and MSN LIFE SCIENCES PRIVATE LIMITED (DMF 41701) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lisinopril records mean?
8 organisations have only inactive Type II DMFs for Lisinopril. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Lisinopril have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Lisinopril on the EDQM register, including ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Taizhou (CN), RICHTER THEMIS MEDICARE (I) PVT. LTD. Vapi (IN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai (CN), HETERO DRUGS LIMITED Hyderabad (IN), EVONIK OPERATIONS GMBH Essen (DE) and LUPIN LIMITED Mumbai (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Lisinopril?
Yes. The latest patent listed for an approved US product containing Lisinopril expires 6 Nov 2035, across 80 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Lisinopril supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lisinopril?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.